A New Type of Evidence

Dawn Lemmane at the 2015 Quantified Self Public Health Symposium


“We are turning the evidence pyramid on its head. We think the single subject trial should be at the top of that pyramid.”

Dawn Lemanne, the founder of Oregon Integrative Oncology, is a pioneering clinician who brings powerful tools of patient involvement and self-assessment to evaluating treatment options. A widely respected researcher, she also organizes the Independent Metabolic Research Group (iMeRG) based in Southern Oregon, a group of over 40 licensed healthcare professionals who meet regularly to discuss their individual single-subject research studies. Here, Dawn describes some of the research her group is conducting, reflecting on what our future concepts of evidence may be when single subject research becomes more commonplace.


Connect

Dawn Lemanne

Dr. Dawn Lemanne is a medical oncologist working on “n of 1” studies for use in cancer and other chronic diseases with a lifestyle component. You can find out more about her work on LinkedIn.

Up Next

Making Health Data Accessible and Actionable, Drew Schiller


Quantified Self Labs is dedicated to sharing stories and insights about the role of data access for personal and public health. We invite you to follow along on quantifiedself.com and @quantifiedself. If you have an interest in joining our growing community and attending the 2016 Quantified Self Public Health Symposium please get in touch.

One clap, two clap, three clap, forty?

By clapping more or less, you can signal to us which stories really stand out.